Atlas Trials

Expanded Access for IMMU-132

Clinical trial NCT04320693 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT04320693
Sponsor
Gilead Sciences
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
Metastatic Triple-Negative Breast Carcinoma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.